Loading...

Teva Pharmaceutical Industries Limited

TEVJFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$29.19
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Teva Pharmaceutical Industries Limited (TEVJF) Stock Competitors & Peer Comparison

See (TEVJF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
TEVJF$29.19+0.00%34B24.12$1.21N/A
IPSEY$51.10+4.11%64.9B31.46$1.56+0.81%
MKKGY$25.99+0.58%55.7B18.18$1.41+1.34%
MKGAF$125.98-3.94%54.5B17.82$7.03+1.52%
TKPHF$32.02-4.57%50.6B72.77$0.44+4.07%
HLNCF$4.54+0.78%43B19.36$0.25+1.99%
SDZNY$84.39+5.08%34.6B38.23$2.09+0.77%
TAIPY$14.00+16.67%18.1B82.35$0.17N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
SGIOY$9.88+0.15%16.8B15.67$0.63+3.29%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

TEVJF vs IPSEY Comparison May 2026

TEVJF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVJF stands at 34B. In comparison, IPSEY has a market cap of 64.9B. Regarding current trading prices, TEVJF is priced at $29.19, while IPSEY trades at $51.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVJF currently has a P/E ratio of 24.12, whereas IPSEY's P/E ratio is 31.46. In terms of profitability, TEVJF's ROE is +0.21%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, TEVJF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for TEVJF.Check IPSEY's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions